The human skin blanching assay for in vivo topical corticosteroid assessment II. Subject- and observer-dependent variation in blanching responses

International Journal of Pharmaceutics

Volumn 152, Issue 2, 1997, Pages 185-192

  Haigh, John M ^a   Meyer, Eric ^a   Smith, Eric W ^a   Kanfer, Isadore ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

Human skin blanching assay; Inter individual variability; Inter observer variability; Intra individual variability; Topical corticosteroids

Indexed keywords

BETAMETHASONE VALERATE; CORTICOSTEROID;

ARTICLE; BIOASSAY; BLEACHING; CONTROLLED STUDY; FEMALE; FOREARM; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE STRENGTH; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SEX DIFFERENCE; SKIN; TECHNIQUE; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION; VISUAL DISCRIMINATION;

EID: 0030857868     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00079-3     Document Type: Article

References (17)

1. Aiache, J-M., Lafaze, C.L., Bouzat, J. and Rabier, R., Evaluation de la disponibilité topique des corticoides par thermographie. J. Pharm. Belg., 35 (1980) 187-195.
2. Clanachan, I., Devitt, H.G., Foreman, M.I. and Kelly, I.P., The human vasoconstrictor assay for topical steroids. J. Pharmacol. Methods, 4 (1980) 209-220.
3. Clarys, P., Wets, L., Barel, A. and Gabard, B., The skin blanching assay with halcinonide, influence of halcinonide concentration and application time. J. Eur. Acad. Dermatol. Venereol., 5 (1995) 250-257.
4. Cornell, R.C. and Stoughton, R.B., Correlation of the vasoconstrictor assay and clinical activity in psoriasis. Arch. Dermatol., 121 (1985) 63-67.
5. Gruvstad, E. and Bengteson, B., A comparison of a new steroid, budesonide, with other topical corticosteroids in the vasoconstriction assay. Drugs Exp. Clin. Res., 6 (1980) 385-390.
6. Haigh, J.M., Meyer, E., Smith, E.W. and Kanfer, I., The human skin blanching assay for in vivo topical corticosteroid assessment: I. Reproducibility of the assay. Int. J. Pharm., 152 (1997) 179-183.
7. Harding, S.M., Sohail, S. and Busse, M.J., Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations. Clin. Exp. Dermatol., 10 (1985) 13-21.
8. Kligman, A.M., Skin permeability: Dermatologic aspects of transdermal drug delivery. Am. Heart J., 108 (1984) 200-206.
9. Larsen, U., Anderson, B., Helles, A. and Juul, P., Systemic within-person variation in the bioavailability of various drugs in healthy volunteers. Eur. J. Clin. Pharmacol., 26 (1984) 769-771.
10. Montenegro, L., Ademola, J.I., Bonina, F.P. and Maibach, H.I., Effect of application time of betamethasone 17-valerate 0.1% cream on skin blanching and stratum corneum drug concentration. Int. J. Pharm., 140 (1996) 51-60.
11. Pershing, L.K., Assessment of topical corticosteroid-induced skin blanching response using the visual McKenzie-Stoughton and colorimetric methods. Drug Info. J., 29 (1995) 923-934.
12. Ryatt, K.S., Feather, J.W., Mehta, A., Dawson, J.B., Cotterill, J.A. and Swallow, R., The stability and blanching efficacy of betamethasone 17-valerate in emulsifying ointment. Br. J. Dermatol., 107 (1982) 71-76.
13. Shah, V.P., Peck, C.C. and Skelly, J.P., Vasoconstriction-skin blanching assay for glucocorticoids-a critique. Arch. Dermatol., 125 (1989) 1558-1561.
14. Stevenson, J.M., Maibach, H.I. and Guy, R.H., Laser Doppler and photoplethysmographic assessments of cutaneous microvasculature., In Maibach, H.I. and Lowe, N.J. (Eds.), Models in Dermatology, Vol 3, Karger, Basel, 1987, pp. 121-140.
15. Stewart, W.D., Runikis, J.O., Verma, S.C. and Wallace, S., Problems in selection of topical anti-inflammatory corticosteroids. C.M.A. J., 108 (1973) 33-38.
16. Stoughton, R.B., Are generic formulations equivalent to trade name topical glucocorticoids. Arch. Dermatol., 123 (1987) 1312-1314.
17. Stoughton, R.B. and Cornell, R.C., Review of super-potent topical corticosteroids. Semin. Dermatol., 6 (1987) 72-76.